Janani Rangaswami, MD
Clinical Associate Professor
Einstein Medical Center / Thomas Jefferson University
Department of Medicine / Nephrology
Philadelphia, PA, USA
Edgar V. Lerma, MD
Clinical Professor of Medicine
UIC/Advocate Christ Medical Center
Department of Medicine
Oak Lawn, IL, USA
Peter A. McCullough, MD, MPH
Consultant Cardiologists and Vice Chief of Internal Medicine
Baylor University Medical Center
Baylor Heart and Vascular Hospital
Department of Internal Medicine
Texas A & M College of Medicine
Division of Cardiology
Dallas, TX, USA
This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes
This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities.
This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.
|
Serves a key reference point bridging the gap between nephrology and cardiology in the cardiac catheterization laboratory
Focuses on the renal impact of cutting edge interventional cardiology procedures
Authors are internationally renowned experts in interventional cardiology, structural cardiology and nephrology
Section 1: Atherosclerotic Cardiovascular Disease Burden in Chronic Kidney Disease
Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes
Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions
Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
Cardiovascular impact of Atherosclerotic Renovascular Disease
Section 2: Therapeutic Considerations with revascularization in Chronic Kidney Disease
Platelet Function testing and antiplatelet agent choice in CKD
Choice of stents and clinical outcomes in patients with CKD
Revascularization strategies in CKD: PCI vs CABG
Approach to revascularization in the potential kidney transplant recipient
Nephrology consultative approach and risk stratification prior to revasc
ularization in CKD
Section 3: Acute Kidney Injury in the catheterization laboratory: Part I
Contrast Induced AKI: Epidemiology, risk stratification and prognosis
Contrast induced AKI: Pathophysiological Mechanisms.
Prevention of Contrast Induced AKI: Summary of volume optimization strategies
Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practices
Intra procedural and operator strategies for reduction of contrast induced AKI
Section 4: Acute Kidney Injury in the catheterization laboratory: Part II
Effect of Percutaneous Ventricular Assist Devices on Renal Function
Renal athero-embolic disease: An underdiagnosed entity
Acute kidney injury with trans catheter aortic valve replacement
Impact of kidney disease in catheter based mitral valve interventio
ns
Acute kidney injury with peripheral vascular interventions
Section 4: Catheter based Reno-vascular interventions
Renal Artery Stenosis: State of the Art in Diagnosis and Management
Renal Denervation: Physiology, scope and current evidence
Section 5: Medical Economics of Kidney Disease in the Catheterization Laboratory
Economic impact of AKI and CKD in cardiac interventions
Biomarkers in early risk stratification and management of post catheterization AKI
Utilization of the cardio nephrology collaborative in the era of value based medicine
This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes
This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities.
This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.
This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes
This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities.
This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.
Section 1: Atherosclerotic Cardiovascular Disease Burden in Chronic Kidney Disease
Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical OutcomesNoninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future DirectionsPeripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional StrategiesCardiovascular impact of Atherosclerotic Renovascular Disease
Section 2: Therapeutic Considerations with revascularization in Chronic Kidney Disease
Platelet Function testing and antiplatelet agent choice in CKDChoice of stents and clinical outcomes in patients with CKDRevascularization strategies in CKD: PCI vs CABGApproach to revascularization in the potential kidney transplant recipientNephrology consultative approach and risk stratification prior to revascularization in CKD
Section 3: Acute Kidney Injury in the catheterization laboratory: Part I
Contrast Induced AKI: Epidemiology, risk stratification and prognosisContrast induced AKI: Pathophysiological Mechanisms.Prevention of Contrast Induced AKI: Summary of volume optimization strategiesPrevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practicesIntra procedural and operator strategies for reduction of contrast induced AKI
Section 4: Acute Kidney Injury in the catheterization laboratory: Part II
Effect of Percutaneous Ventricular Assist Devices on Renal FunctionRenal athero-embolic disease: An underdiagnosed entityAcute kidney injury with trans catheter aortic valve replacement Impact of kidney disease in catheter based mitral valve interventionsAcute kidney injury with peripheral vascular interventions
Section 4: Catheter based Reno-vascular interventions
Renal Artery Stenosis: State of the Art in Diagnosis and ManagementRenal Denervation: Physiology, scope and current evidence
Section 5: Medical Economics of Kidney Disease in the Catheterization Laboratory
Economic impact of AKI and CKD in cardiac interventionsBiomarkers in early risk stratification and management of post catheterization AKIUtilization of the cardio nephrology collaborative in the era of value based medicine
Janani Rangaswami, MD
Clinical Associate Professor
Einstein Medical Center / Thomas Jefferson University
Department of Medicine / Nephrology
Philadelphia, PA, USA
Edgar V. Lerma, MD
Clinical Professor of Medicine
UIC/Advocate Christ Medical Center
Department of Medicine
Oak Lawn, IL, USA
Peter A. McCullough, MD, MPH
Consultant Cardiologists and Vice Chief of Internal Medicine
Baylor University Medical Center
Baylor Heart and Vascular Hospital
Department of Internal Medicine
Texas A & M College of Medicine
Division of Cardiology
Dallas, TX, USA
Über den Autor
Janani Rangaswami, MD
Clinical Associate Professor
nn
Einstein Medical Center / Thomas Jefferson University
nn
Department of Medicine / Nephrology
nn
Philadelphia, PA, USA
nn
nn
Edgar V. Lerma, MD
Clinical Professor of Medicine
nn
UIC/Advocate Christ Medical Center
nn
Department of Medicine
nn
Oak Lawn, IL, USA
nn
nn
Peter A. McCullough, MD, MPH
Consultant Cardiologists and Vice Chief of Internal Medicine
nn
Baylor University Medical Center
nn
Baylor Heart and Vascular Hospital
nn
Department of Internal Medicine
nn
Texas A & M College of Medicine
nn
Division of Cardiology
nn
Dallas, TX, USA
Inhaltsverzeichnis
Section 1: Atherosclerotic Cardiovascular Disease Burden in Chronic Kidney Disease
Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes
Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions
Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
Cardiovascular impact of Atherosclerotic Renovascular Disease
Section 2: Therapeutic Considerations with revascularization in Chronic Kidney Disease
Platelet Function testing and antiplatelet agent choice in CKD
Choice of stents and clinical outcomes in patients with CKD
Revascularization strategies in CKD: PCI vs CABG
Approach to revascularization in the potential kidney transplant recipient
Nephrology consultative approach and risk stratification prior to revasc
ularization in CKD
Section 3: Acute Kidney Injury in the catheterization laboratory: Part I
Contrast Induced AKI: Epidemiology, risk stratification and prognosis
Contrast induced AKI: Pathophysiological Mechanisms.
Prevention of Contrast Induced AKI: Summary of volume optimization strategies
Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practices
Intra procedural and operator strategies for reduction of contrast induced AKI
Section 4: Acute Kidney Injury in the catheterization laboratory: Part II
Effect of Percutaneous Ventricular Assist Devices on Renal Function
Renal athero-embolic disease: An underdiagnosed entity
Acute kidney injury with trans catheter aortic valve replacement
Impact of kidney disease in catheter based mitral valve interventio
ns
Acute kidney injury with peripheral vascular interventions
Section 4: Catheter based Reno-vascular interventions
Renal Artery Stenosis: State of the Art in Diagnosis and Management
Renal Denervation: Physiology, scope and current evidence
Section 5: Medical Economics of Kidney Disease in the Catheterization Laboratory
Economic impact of AKI and CKD in cardiac interventions
Biomarkers in early risk stratification and management of post catheterization AKI
Utilization of the cardio nephrology collaborative in the era of value based medicine
Klappentext
rnrnThis book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes rnrnrnThis book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities. rnrnrnThis book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease. rn
Serves a key reference point bridging the gap between nephrology and cardiology in the cardiac catheterization laboratory
Focuses on the renal impact of cutting edge interventional cardiology procedures
Authors are internationally renowned experts in interventional cardiology, structural cardiology and nephrology
